Public limited company · Lo-Reninge · incorporated on 12/05/1989 · 8,1 ETP
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 609,1 k € | +68.4% | 361,7 k € | -34.6% | 552,7 k € | +160.2% | 212,4 k € | -47.7% | 406,2 k € | +46.7% | 276,9 k € | +12.6% | 245,9 k € | +19.3% | 206,0 k € | -2.6% | 211,6 k € | -34.8% | 324,4 k € | -10.2% | 361,2 k € | -25.2% | 483,2 k € | +14.2% | 423,0 k € | -41.6% | 723,9 k € | +53.3% | 472,3 k € | -12.1% | 537,1 k € | +37.6% | 390,4 k € | -17.4% | 472,9 k € | +33.9% | 353,2 k € | |
| EBITDA | 89,7 k € | +193.4% | -96,0 k € | -350.5% | 38,3 k € | +139.8% | -96,3 k € | -177.8% | 123,8 k € | +349.5% | 27,5 k € | -40.0% | 45,9 k € | +125.9% | 20,3 k € | -68.3% | 64,2 k € | -60.8% | 163,5 k € | -25.6% | 219,9 k € | -41.8% | 377,6 k € | +28.9% | 293,0 k € | -50.3% | 589,4 k € | +66.7% | 353,6 k € | -21.9% | 453,0 k € | +17.0% | 387,2 k € | -17.8% | 471,1 k € | +34.6% | 349,9 k € | |
| Operating profit | -102,4 k € | +65.9% | -300,3 k € | -73.8% | -172,8 k € | +20.9% | -218,3 k € | -1248.4% | 19,0 k € | +130.7% | -62,0 k € | -66.5% | -37,2 k € | +16.4% | -44,5 k € | -197.0% | -15,0 k € | -107.1% | 210,5 k € | +670.3% | -36,9 k € | +89.4% | -348,2 k € | -328.0% | 152,8 k € | -70.6% | 519,2 k € | +84.2% | 282,0 k € | -23.7% | 369,3 k € | +19.4% | 309,2 k € | -29.3% | 437,4 k € | +32.3% | 330,5 k € | |
| Profit/loss | -69,9 k € | +75.5% | -285,6 k € | -79.5% | -159,1 k € | +18.5% | -195,3 k € | -506.4% | 48,0 k € | +319.3% | -21,9 k € | -128.8% | -9,6 k € | +59.6% | -23,7 k € | -285.0% | 12,8 k € | -94.4% | 228,8 k € | +1049.7% | -24,1 k € | +92.6% | -324,7 k € | -334.7% | 138,4 k € | -71.6% | 486,8 k € | +76.3% | 276,1 k € | -14.4% | 322,6 k € | -1.6% | 327,8 k € | -27.9% | 454,9 k € | +43.0% | 318,0 k € | |
| Equity | 2,7 M € | -2.5% | 2,8 M € | -9.4% | 3,0 M € | -5.0% | 3,2 M € | -5.7% | 3,4 M € | +1.4% | 3,4 M € | -0.6% | 3,4 M € | -0.3% | 3,4 M € | -0.7% | 3,4 M € | +0.4% | 3,4 M € | +7.2% | 3,2 M € | -0.8% | 3,2 M € | -9.2% | 3,5 M € | +4.1% | 3,4 M € | -1.6% | 3,4 M € | +8.8% | 3,2 M € | +11.4% | 2,8 M € | +13.1% | 2,5 M € | +13.9% | 2,2 M € | |
| Total assets | 4,0 M € | -10.7% | 4,4 M € | -5.7% | 4,7 M € | +7.3% | 4,4 M € | -2.3% | 4,5 M € | +8.7% | 4,1 M € | +11.0% | 3,7 M € | -4.0% | 3,9 M € | +4.1% | 3,7 M € | +3.2% | 3,6 M € | +5.8% | 3,4 M € | -6.3% | 3,6 M € | +0.2% | 3,6 M € | +1.3% | 3,6 M € | -1.3% | 3,6 M € | +2.4% | 3,6 M € | +5.1% | 3,4 M € | +5.8% | 3,2 M € | +6.6% | 3,0 M € | |
| Cash | 354,8 k € | +2.2% | 347,2 k € | -26.7% | 473,6 k € | +200.0% | 157,8 k € | -67.4% | 484,4 k € | +157.4% | 188,2 k € | -38.0% | 303,6 k € | -18.3% | 371,8 k € | +327.9% | 86,9 k € | -70.3% | 292,4 k € | +1883.6% | 14,7 k € | -43.5% | 26,1 k € | +499.3% | 4,3 k € | -80.8% | 22,6 k € | -78.2% | 103,9 k € | +6294.1% | 1,6 k € | -98.7% | 127,4 k € | -6.2% | 135,7 k € | -38.7% | 221,4 k € | |
| Debts | 1,3 M € | -24.0% | 1,7 M € | +1.0% | 1,7 M € | +40.7% | 1,2 M € | +8.4% | 1,1 M € | +39.8% | 780,9 k € | +123.7% | 349,1 k € | -29.4% | 494,6 k € | +70.6% | 289,9 k € | +33.4% | 217,4 k € | -3.7% | 225,6 k € | -50.5% | 456,0 k € | +267.4% | 124,1 k € | -42.7% | 216,7 k € | +3.0% | 210,5 k € | -47.7% | 402,8 k € | -27.0% | 551,7 k € | -9.2% | 607,6 k € | -6.1% | 647,3 k € | |
| Staff | 8,1 | 7,2 | 8 | 8,7 | 5,5 | 4,8 | 3,8 | 3,3 | 3,2 | 2,7 | 2,5 | 2,1 | 2,3 | 2,7 | 2,2 | 1,5 | — | — | — | |||||||||||||||||||
Public limited company loss-making in the latest fiscal year.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DUBAVO is a Public limited company incorporated in 1989. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Lo-Reninge. It employs on average 8,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette